Sky9 Capital
云九资本
elsewhere's corpus does not cover Sky9 Capital. The retrieved materials focus on 心资本 (Heart Capital / SoulCapital), a separate China-based early-stage VC fund founded in 2022 by former Lightspeed China partners, with no mention of Sky9 Capital in any of the provided chunks.
AI-generated — may contain errors, please verify.
Coverage
Former LiblibAI Co-founder Raises Tens of Millions in USD for New Startup, Using "World Simulator" to Break Into AI Entertainment
Find a "milk-tea kind" of happiness in a self-created virtual world.
Another VC Rebrands with a New Name
The twentieth year of local iteration.
Critique always sounds clever, just as creation always looks clumsy | After judging the Xiaohongshu Indie Developer Competition, I have so much I need to get off my chest
Between cleverness and clumsiness, I choose clumsiness.
2024, When Everyone Stands at a Crossroads: 96 Investors' Decisions
Deciding is easy. Waiting is hard.
To AI Founders: In 2025, Go to These VCs for Funding | Debriefing a Year in Primary Markets with Jing Liu of "Waves"
"2024: Who's Still Actively Investing in AI?"
To AI Founders: In 2025, Go to These VCs for Funding | A Year-in-Review of the Primary Market with "An Yong" and Jing Liu
A Look at 2024's AI Innovations in China: From Models to Hardware, From Applications to the Rise of Super-Individuals
Let's preserve the AI innovations that brought us excitement and encouragement in 2024.
From Models to Hardware, From Applications to the Rise of Super-Individuals | A Review of China's AI Innovations in 2024
AI in China ②: "We're a Billion-RMB Company Now, and AI Helped Us Grow Revenue Another 30%" | Case Studies and Insights from Nuanwa Technology and Baiyaoshi
"My conviction in AI keeps growing."
AI in China ②: "We're a Billion-RMB Company Now, and AI Helped Us Grow Revenue Another 30%" | Case Studies and Insights from Nuanwa Technology and Baiyaoshi
AI in China: 10 Enterprise Deployment Cases and Their Business Implications | A Conversation with Ren Xin: AI Entrepreneur and Investor
Over the past six months, Ren Xin and I have been immersed in AI day in and day out, and we've observed ten real-world AI application stories.
AI in China ①: 10 Enterprise Deployment Cases and Their Business Implications | A Conversation with Ren Xin: AI Entrepreneur and Investor
5Y News | 5Y Capital Portfolio Company ReviR Therapeutics Raises $30 Million in Series A Funding
Continuing to advance "oral gene therapy" through AI+RNA.
Exclusive | Moonshot AI's valuation reaches $3 billion in new round; Tencent joins after Alibaba
A full list of Moonshot AI's investors to date.
Money, Contradictions, and ESG
*Who Cares Wins*
Three Barometers for the Primary Market, for Your Reference
The bilateral order of the primary market is being restructured on both sides.
Capital O Closes First Fund, Post-90s GP Enters the Stage
Technological breakthroughs deserve more attention than market turbulence.
Linear Capital Leads Pre-A Round in CloudNat Technology, Follows On in Series A with Pro-Rata Allocation | Linear News
Dedicated to driving agile digital transformation for enterprises.
MaHui | Serval Tech Announces Completion of Series A Financing Led by Source Code Capital
Building the next generation of data security solutions.
Linear News | SynBio Startup "Biosys" Secures Two Funding Rounds in Six Months, Linear Capital Leads Angel Round
"Besheng Bio's" long-term goal is to build a complete biotech ecosystem based on the ArchiCel architecture — in essence, to create the Windows + x86 equivalent for the biotechnology industry.
Biosys Biotechnology Closes Angel Round, Total Funding Exceeds 100 Million Yuan | Oasis Capital
Counselor Vitality
Metaverse social platform "BUD" announced the completion of a $15 million Series A+ funding round, with Source Code Capital participating in the investment.
The Next Generation of UGC Social Platforms
February: When the Tiger Roars, the Wind Rises | 5Y News Monthly
The big news from last month.
5Y News | AI+RNA Startup ReviR Therapeutics Closes Tens of Millions of Dollars in Pre-A Round
Using AI algorithms and gene technology to drive targeted RNA drug development.
2022, the Door Opens to the Future | 5Y News Monthly
The big news from last month.
5Y News | AI Microbiome Drug Developer "Unknown" Closes Nearly $100 Million Series B Financing
Launching a new AI×BT strategy.
November: Foresight and Boundless Imagination | 5Y News Monthly
The big news from last month.
5Y News | Signet Therapeutics Raises Nearly $10 Million to Power AI-Enabled Innovative Targeted Drug Development Through Disease Modeling Platform
Advancing pharmaceutical innovation in China.
As Fierce as August | 5Y News Monthly
The big news from last month.
5Y News | Neox Biotech Completes Tens of Millions of Dollars in Series A+ Funding to Advance Innovative Drug Pipeline
5Y Capital continues to provide support.
To Better Kick Off March | 5Y News Monthly
The major events of February.
5Y News｜Neox Biotech Completes $30 Million Series A Round, 5Y Capital Continues Support
Exploring the most cutting-edge drug modalities.
General-Purpose Intelligent Chip Designer Biren Technology Completes Major Pre-B Round Financing
Dedicated to achieving breakthroughs in domestically produced high-end general-purpose AI computing chips.
